Effects of adrenaline and noradrenaline on euglobulin lysis time and effects of adrenergic receptor blocking agents on shortening of lysis time by adrenaline.
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004837:Epinephrine / Q000494:pharmacology*; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D012712:Serum Globulins / Q000378:metabolism*; D013565:Sympatholytics / Q000494:pharmacology*; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D012712:Serum Globulins; D013565:Sympatholytics; D010643:Phenoxybenzamine; D009638:Norepinephrine; D004837:Epinephrine